Compounds > arabinofuranosylcytosine triphosphate

arabinofuranosylcytosine triphosphate and Down Syndrome

arabinofuranosylcytosine triphosphate has been researched along with Down Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buck, S; Ge, Y; Jensen, TL; Matherly, LH; Ravindranath, Y; Stout, ML; Tatman, DA; Taub, JW; Thomas, RL	1
Buck, SA; Gurney, JG; Matherly, LH; Ravindranath, Y; Stout, ML; Taub, JW	1

Other Studies

2 other study(ies) available for arabinofuranosylcytosine triphosphate and Down Syndrome

Article	Year
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. Journal of the National Cancer Institute, 2005, Feb-02, Volume: 97, Issue:3 Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Blotting, Western; Child; Cytarabine; Cytidine Deaminase; DNA-Binding Proteins; Down Syndrome; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Humans; Leukemia, Megakaryoblastic, Acute; Polymerase Chain Reaction; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Up-Regulation	2005
Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood, 1996, Apr-15, Volume: 87, Issue:8 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Line, Transformed; Cells, Cultured; Child; Child, Preschool; Chromosomes, Human, Pair 21; Cystathionine beta-Synthase; Cytarabine; Deoxycytosine Nucleotides; Disease-Free Survival; Down Syndrome; Female; Herpesvirus 4, Human; Homocysteine; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Methotrexate; Myelodysplastic Syndromes; Neoplastic Stem Cells; Remission, Spontaneous; Survival Rate	1996

Article

Year

GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.

Journal of the National Cancer Institute, 2005, Feb-02, Volume: 97, Issue:3

Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Blotting, Western; Child; Cytarabine; Cytidine Deaminase; DNA-Binding Proteins; Down Syndrome; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Humans; Leukemia, Megakaryoblastic, Acute; Polymerase Chain Reaction; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Up-Regulation

2005

Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.

Blood, 1996, Apr-15, Volume: 87, Issue:8

Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Line, Transformed; Cells, Cultured; Child; Child, Preschool; Chromosomes, Human, Pair 21; Cystathionine beta-Synthase; Cytarabine; Deoxycytosine Nucleotides; Disease-Free Survival; Down Syndrome; Female; Herpesvirus 4, Human; Homocysteine; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Methotrexate; Myelodysplastic Syndromes; Neoplastic Stem Cells; Remission, Spontaneous; Survival Rate

1996